open access

Vol 58, No 2 (2007)
Postgraduate education
Published online: 2007-03-13
Submitted: 2013-02-15
Get Citation

Glucocorticoid-induced osteoporosis

Wanda Foltyn, Beata Kos-Kudła, Bogdan Marek, Dariusz Kajdaniuk, Joanna Głogowska-Szeląg, Lucyna Siemińska, Janusz Strzelczyk, Małgorzata Borowska
Endokrynologia Polska 2007;58(2):170-176.

open access

Vol 58, No 2 (2007)
Postgraduate education
Published online: 2007-03-13
Submitted: 2013-02-15

Abstract

Prolonged glucocorticoids administration is the most common cause of secondary osteoporosis. It is estimated that 30% to 50% of chronic glucocorticoids users experience vertebral or hip fractures. The highest bone loss (up to 30% in some studies) is observed in the first six months of treatment. Only a minority of patients who take chronic glucocorticoids receive optimal osteoporosis diagnosis, prevention, and/or treatment. The aim of this paper is to present the pathophysiology of glucocorticoid-induced osteoporosis, as well as some guidelines on diagnostic, preventive and therapeutic strategies for this disorder in an effort to promote the greater awareness of it.

Abstract

Prolonged glucocorticoids administration is the most common cause of secondary osteoporosis. It is estimated that 30% to 50% of chronic glucocorticoids users experience vertebral or hip fractures. The highest bone loss (up to 30% in some studies) is observed in the first six months of treatment. Only a minority of patients who take chronic glucocorticoids receive optimal osteoporosis diagnosis, prevention, and/or treatment. The aim of this paper is to present the pathophysiology of glucocorticoid-induced osteoporosis, as well as some guidelines on diagnostic, preventive and therapeutic strategies for this disorder in an effort to promote the greater awareness of it.
Get Citation

Keywords

glucocorticoid-induced osteoporosis; pathophysiology; diagnosis; prevention; treatment

About this article
Title

Glucocorticoid-induced osteoporosis

Journal

Endokrynologia Polska

Issue

Vol 58, No 2 (2007)

Pages

170-176

Published online

2007-03-13

Bibliographic record

Endokrynologia Polska 2007;58(2):170-176.

Keywords

glucocorticoid-induced osteoporosis
pathophysiology
diagnosis
prevention
treatment

Authors

Wanda Foltyn
Beata Kos-Kudła
Bogdan Marek
Dariusz Kajdaniuk
Joanna Głogowska-Szeląg
Lucyna Siemińska
Janusz Strzelczyk
Małgorzata Borowska

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl